TheEdgeResearch
Home / Stocks / EOFBY

Ecofibre Limited (EOFBY)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.84 ▲ +0.00%
Market Cap
$73.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.54
52-Wk Range
0.8438-1.36
CEO
Eric Wang
Country
AU
Currency
USD

Ecofibre Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.84, up 0.00% on the session, giving a market capitalisation of $73.7M. On trailing twelve-month figures it carries a trailing P/E of -10.62, a net margin of -158.5%. Its beta of 1.54 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-10.62
Price / Sales
3.98
Price / Book
11.49
EV / EBITDA
-3.43
Gross margin
-3.9%
Operating margin
-53.7%
Net margin
-158.5%
Return on equity
—
Debt / equity
0.64
Current ratio
1.80
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2022-04-14
Headquarters
Sydney, NSW, AU
About Ecofibre Limited

Ecofibre Limited, along with its various subsidiaries, is engaged in the cultivation, production, marketing, and sale of hemp-based products across the United States and Australia. The company organizes its operations through three distinct segments: Ananda Health, Ananda Food, and Hemp Black. Its comprehensive product offerings include CBD solutions for both human and pet consumption, as well as topical health and beauty items. Additionally, Ecofibre provides hemp-derived food products and a diverse array of textile and other hemp goods. Founded in 2009, Ecofibre Limited is headquartered in Sydney, Australia.

Comparable companies

Ecofibre Limited is most often compared with the following Healthcare names:

BIOGFCKMTFEEOIFETXPFGDNSFINNPFKDEVFKIARFSYMQYTIHE
More research on EOFBY
EOFBY technical analysis EOFBY TheEdge Score Compare against peers
Open full interactive analysis & DCF →